Subsidy Tracker Parent Company Summary

Parent Company Name: 
Merck
Ownership Structure: 
publicly traded (ticker symbol MRK)
Headquartered in: 
New Jersey
Major Industry: 
pharmaceuticals
Specific Industry: 
pharmaceuticals
Subsidy SummarySubsidy ValueNumber of Awards
State/Local$124,231,77860
Federal (grants and allocated tax credits)$12,719,19428
TOTAL$136,950,97288
Loan / Bailout SummaryTotal Face ValueNumber of Awards
State/Local loans, bond financing and venture capital$5,000,0001
Federal loans, loan guarantees and bailout assistance (not including repayments)$00
TOTAL$5,000,0001
Time Period for State and Local Awards: 

Earliest year of data: 1999. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this parent company are for the period since 2009.

Time Period for Federal Awards: 

FY2000 to the present

Notes: 

Dollar totals do not include awards for which no subsidy value is disclosed.

Associated Names: 

C3I; CHEROKEE PHARMACEUTICALS; CUBIST PHARMACEUTICALS; GLYCOFI; ILLUMIGEN BIOSCIENCES; INSPIRE PHARMACEUTICALS; INTERVET; KBI; MERCK; MERCK 2015; MERCK AND; MERCK ANIMAL HEALTH; MERCK SHARP AND DOHME; NOVIRIO PHARMACEUTICALS, INC; SCHERING

Links: 

For a summary of this company's regulatory violations see its Violation Tracker summary page here.

For an overview of this company's accountability track record, read its Corporate Rap Sheet here.

For more details on misconduct by this company, see its entry in the Project On Government Oversight's Federal Contractor Misconduct Database.

For a summary of this company's federal contracts, see its page on Fedspending.

For an overview of political contributions associated with this company, see its Follow the Money page.


Top 5 States for state/local awardsTotal Subsidy $Number of Awards
North Carolina$69,542,32221
Pennsylvania$39,840,60015
New Jersey$8,804,2503
Virginia$4,639,3835
Louisiana$995,6241
All other$409,59915

Individual Subsidy Records:

Download results as CSV or XML
Company Location Subsidy Source Year Subsidy Valuesort icon Loan/Bailout Value Type of Subsidy
Merck & Co., Inc. North Carolina state 2004 $24,000,000 grant/loan hybrid program
Merck, Sharp & Dohme Corp. Pennsylvania state 2011 $19,590,893 tax credit/rebate
Merck Sharp & Dohme Corp. North Carolina state 2015 $12,098,272 tax credit/rebate
Merck, Sharp & Dohme Corp. Pennsylvania state 2012 $10,263,039 tax credit/rebate
Merck & Co., Inc. North Carolina state 2012 $6,651,352 tax credit/rebate
Merck & Co., Inc. North Carolina state 2010 $6,007,498 tax credit/rebate
Merck Sharp & Dohme Corp. North Carolina state 2004 $5,514,655 grant
Merck Sharp & Dohme Corp. North Carolina state 2016 $4,302,041 tax credit/rebate
Intervet Inc. New Jersey state 2012 $3,981,600 grant
Merck & Co. Inc. New Jersey state 2000 $3,948,650 grant
Merck & Co., Inc. North Carolina state 2008 $2,940,954 tax credit/rebate
Merck & Co., Inc. North Carolina state 2011 $2,774,342 tax credit/rebate
Merck & Co., Inc. Pennsylvania state 2009 $1,677,793 tax credit/rebate
Merck & Co., Inc. North Carolina state 2009 $1,579,355 tax credit/rebate
OPTIMER PHARMACEUTICALS INC United States federal 2005 $1,521,978 federal grant
Merck Virginia state 2007 $1,500,000 grant
Merck, Sharp & Dohme Corp. Pennsylvania state 2010 $1,321,420 tax credit/rebate
Merck Sharpe & Dohme Virginia state 2016 $1,300,000 grant
Merck & Co Virginia state 2016 $1,300,000 grant
Merck Sharp & Dohme Corp. North Carolina state 2013 $1,230,023 tax credit/rebate
Merck & Co., Inc. Pennsylvania state $1,200,000 grant
Cherokee Pharmaceuticals, LLC Pennsylvania state $1,200,000 grant
OPTIMER PHARMACEUTICALS INC United States federal 2009 $1,000,000 federal grant
OPTIMER PHARMACEUTICALS INC United States federal 2008 $1,000,000 federal grant
Merck Animal Health Louisiana state 2012 $995,624 property tax abatement
Merck & Co., Inc. New Jersey state 1999 $874,000 grant
GLYCOFI, INC. United States federal 2002 $800,000 federal grant
Merck & Co., Inc. North Carolina state 2008 $770,277 tax credit/rebate
GLYCOFI INC United States federal 2003 $752,062 federal grant
Merck & Co., Inc. Pennsylvania state $735,000 training reimbursement
Cherokee Pharmaceuticals, LLC Pennsylvania state $699,000 tax credit/rebate
OPTIMER PHARMACEUTICALS INC United States federal 2005 $612,862 federal grant
GLYCOFI, INC. United States federal 2004 $600,000 federal grant
GLYCOFI, INC. United States federal 2003 $600,000 federal grant
NOVIRIO PHARMACEUTICALS, INC United States federal 2001 $589,490 federal grant
OPTIMER PHARMACEUTICALS INC United States federal 2006 $578,386 federal grant
CUBIST PHARMACEUTICALS, INC United States federal 2002 $532,716 federal grant
Merck Sharp & Dohme Corp. North Carolina state 2015 $521,964 tax credit/rebate
C3i, Inc. Pennsylvania state $512,000 tax credit/rebate
C3i, Inc. Pennsylvania state 2014 $512,000 tax credit/rebate
Merck, Sharp & Dohme Corp. Pennsylvania state 2017 $506,455 tax credit/rebate
KBI United States federal 2004 $500,000 federal grant
CUBIST PHARMACEUTICALS, INC United States federal 2004 $500,000 federal grant
C3i, Inc. Pennsylvania state $500,000 grant
CUBIST PHARMACEUTICALS, INC United States federal 2001 $485,720 federal grant
C3i Incorporated Pennsylvania state $458,000 tax credit/rebate
Merck & Co., Inc. North Carolina state 2008 $452,785 tax credit/rebate
Merck (2015) Virginia state 2016 $450,000 training reimbursement
CUBIST PHARMACEUTICALS, INC United States federal 2000 $424,463 federal grant
C3i Incorporated Pennsylvania state $400,000 grant
ILLUMIGEN BIOSCIENCES INC United States federal 2003 $271,747 federal grant
Merck & Co., Inc. Pennsylvania state $265,000 training reimbursement
CUBIST PHARMACEUTICALS, INC United States federal 2002 $258,814 federal grant
CUBIST PHARMACEUTICALS, INC United States federal 2003 $258,205 federal grant
GLYCOFI INC United States federal 2004 $238,348 federal grant
CUBIST PHARMACEUTICALS, INC United States federal 2003 $236,300 federal grant
Merck & Co., Inc. North Carolina state 2012 $220,500 tax credit/rebate
CUBIST PHARMACEUTICALS, INC United States federal 2001 $208,500 federal grant
Merck & Co., Inc. North Carolina state 2012 $160,804 tax credit/rebate
KBI United States federal 2015 $149,884 federal grant
Merck & Co., Inc. North Carolina state 2012 $130,000 tax credit/rebate
GLYCOFI INC United States federal 2002 $100,000 federal grant
GLYCOFI INC United States federal 2004 $100,000 federal grant
NOVIRIO PHARMACEUTICALS, INC United States federal 2000 $100,000 federal grant
OPTIMER PHARMACEUTICALS INC United States federal 2004 $100,000 federal grant
OPTIMER PHARMACEUTICALS INC United States federal 2003 $100,000 federal grant
KBI United States federal 2003 $99,719 federal grant
Merck & Co., Inc. Virginia state 2010 $89,383 training reimbursement
Schering Corporation Florida state 2007 $84,000 tax credit/rebate
Merck & Co., Inc. North Carolina state 1999 $67,000 grant
Merck & Co., Inc. North Carolina state 2011 $55,000 tax credit/rebate
C3I,Incorporated New York local 2002 $50,592 grant
Schering-Plough Animal Health Corporation Delaware state 2008 $45,400 training reimbursement
Schering-Plough Animal Health Corporation Delaware state 2007 $43,943 training reimbursement
Merck & Co., Inc. North Carolina state 2001 $33,000 grant
Intervet, Inc. Delaware state 2011 $29,450 training reimbursement
Intervet, Inc. Delaware state 2015 $29,352 training reimbursement
Intervet, Inc. Delaware state 2016 $28,919 training reimbursement
Schering-Plough Animal Health Corporation Delaware state 2006 $21,485 training reimbursement
Intervet Delaware state 2003 $19,925 training reimbursement
Merck & Co., Inc. North Carolina state 2011 $18,000 tax credit/rebate
Intervet, Inc. Delaware state 2013 $16,236 training reimbursement
Inspire Pharmaceuticals, Inc. North Carolina state 2008 $14,500 tax credit/rebate
ILLUMIGEN BIOSCIENCES INC Washington state 2004 $11,367 tax credit/rebate
C3I New Hampshire state 2014 $9,576 training reimbursement
C3I, Inc. New Hampshire state 2012 $9,105 training reimbursement
C3I New Hampshire state 2015 $5,908 training reimbursement
ILLUMIGEN BIOSCIENCES INC Washington state 2005 $4,341 tax credit/rebate
Cherokee Pharmaceuticals, LLC Pennsylvania state $5,000,000 loan or bond financing
Intervet, Inc. Nebraska state 2001 undisclosed tax credit/rebate
Intervet, Inc. Nebraska state 2007 undisclosed tax credit/rebate
ILLUMIGEN BIOSCIENCES INC Washington state 2006 undisclosed tax credit/rebate
OPTIMER PHARMACEUTICALS, INC. New Jersey state undisclosed tax credit/rebate; property tax abatement
C3I, INC California local 2012 undisclosed tax credit/rebate
Download results as CSV or XML